Susannah Leigh Rose

Susannah Leigh Rose

Auto-generated profile, based on publicly available information

Susannah Leigh Rose

Department of Biomedical Informatics & Center for Biomedical Ethics and Society Vanderbilt University Medical Center Nashville Tennessee USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2018 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
KMKathryn A. Martinez
Kathryn A. Martinez
MRMark Rood
Mark Rood
NJNikhyl Jhangiani
Nikhyl Jhangiani
LKLei Kou
Lei Kou
SRSusannah Rose
Susannah Rose
MRMichael B. Rothberg
Michael B. Rothberg

1 March 2017 in JAMA Internal Medicine
Verified
Journal Article
Closed access
PDF file
SRSusannah L. Rose
Susannah L. Rose
JHJanelle Highland
Janelle Highland
MKMatthew T. Karafa
Matthew T. Karafa
SJSteven Joffe
Steven Joffe
Importance Patient advocacy organizations (PAOs) are influential health care stakeholders that provide direct counseling and education for patients, engage in policy advocacy, and shape research agendas. Many PAOs report having financial relationships with for-profit industry, yet little is known about the nature of these relationships. Objective To describe the nature of industry funding and partnerships between PAOs and for-profit companies in the United States. Design, Setting, and Participants A survey was conducted from September 1, 2013, to June 30, 2014, of a nationally representative random sample of 439 PAO leaders, representing 5.6% of 7865 PAOs identified in the United States. Survey questions addressed the nature of their activities, their financial relationships with industry, and the perceived effectiveness of their conflict of interest policies. Main Outcomes and Measures Amount and sources of revenue as well as organizational experiences with and policies regarding financial conflict of interest. Results Of the 439 surveys mailed to PAO leaders, 289 (65.8%) were returned with at least 80% of the questions answered. The PAOs varied widely in terms of size, funding, activities, and disease focus. The median total revenue among responding organizations was $299 140 (interquartile range, $70 000-$1 200 000). A total of 165 of 245 PAOs (67.3%) reported receiving industry funding, with 19 of 160 PAOs (11.9%) receiving more than half of their funding from industry. Among the subset of PAOs that received industry funding, the median amount was $50 000 (interquartile range, $15 000-$200 000); the median proportion of industry support derived from the pharmaceutical, device, and/or biotechnology sectors was 45% (interquartile range, 0%-100%). A total of 220 of 269 respondents (81.8%) indicated that conflicts of interest are very or moderately relevant to PAOs, and 94 of 171 (55.0%) believed that their organizations’ conflict of interest policies were very good. A total of 22 of 285 PAO leaders (7.7%) perceived pressure to conform their positions to the interests of corporate donors. Conclusions and Relevance Patient advocacy organizations engage in wide-ranging health activities. Although most PAOs receive modest funding from industry, a minority receive substantial industry support, raising added concerns about independence. Many respondents report a need to improve their conflict of interest policies to help maintain public trust.

1 January 2013 in Journal of Law, Medicine & Ethics
Verified
Journal Article
Closed access
SRSusannah L. Rose
Susannah L. Rose

22 May 2024 in Chest
Verified
Journal Article
Open access
SRSusannah L. Rose
Susannah L. Rose
DSDevora Shapiro
Devora Shapiro
Artificial intelligence (AI) is increasingly being used in healthcare, and without an ethically supportable, standard approach to knowing when patients should be informed about AI, hospital systems and clinicians run the risk of fostering mistrust among their patients and the public. Therefore, hospital leaders need guidance on when to tell patients about the use of AI in their care. In this paper we provide such guidance. To determine which AI technologies fall into each of the identified categories (no notification/no informed consent (IC), notification-only, and formal IC), we propose that AI use-cases should be evaluated using the following criteria: 1) AI model autonomy; 2) departure from standards of practice; 3) whether or not the AI model is patient facing; 4) clinical risk introduced by the model; and 5) administrative burdens. We take each of these in turn, using a case example of AI in healthcare to illustrate our proposed framework. As AI becomes more commonplace in healthcare, our proposal may serve as a starting point for creating consensus on standards for notification and IC for the use of AI in patient care.

11 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SRSusannah L. Rose
Susannah L. Rose
RSRuchi M. Sanghani
Ruchi M. Sanghani
CSCory Schmidt
Cory Schmidt
MKMatthew T. Karafa
Matthew T. Karafa
EKEric Kodish
Eric Kodish
GCGuy M. Chisolm
Guy M. Chisolm
Academic literature extensively documents gender disparities in the medical profession with regard to salary, promotion, and government funded research. However, gender differences in the value of financial ties to industry have not been adequately studied despite industry’s increasing contribution to income and research funding to physicians in the U.S. We analyzed publicly reported financial relationships among 747,603 physicians and 432 pharmaceutical, device and biomaterials companies. Demographic and payment information were analyzed using hierarchical regression models to determine if statistically significant gender differences exist in physician-industry interactions regarding financial ties, controlling for key covariates. In 2011, 432 biomedical companies made an excess of $17,991,000 in payments to 220,908 physicians. Of these physicians, 75.1% were male. Female physicians, on average, received fewer total dollars (-$3,598.63, p<0.001) per person than men. Additionally, female physicians received significantly lower amounts for meals (-$41.80, p<0.001), education (-$1,893.14, p<0.001), speaker fees (-$2,898.44, p<0.001), and sponsored research (-$15,049.62, p=0.05). For total dollars, an interaction between gender and institutional reputation was statistically significant, implying that the differences between women and men differed based on industry’s preference for an institution, with larger differences at higher reputation institutions. Female physicians receive significantly lower compensation for similarly described activities than their male counterparts after controlling for key covariates. As regulations lead to increased transparency regarding these relationships, efforts to standardize compensation should be considered to promote equitable opportunities for all physicians.

8 January 2022 in Health and Technology
Verified
Journal Article
Closed access
PDF file
BBBethany Bruno
Bethany Bruno
SSScott Steele
Scott Steele
JCJustin Carbone
Justin Carbone
KSKatherine Schneider
Katherine Schneider
LPLori Posk
Lori Posk
SRSusannah L. Rose
Susannah L. Rose